Corient Private Wealth’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.53M Buy
17,380
+4,866
+39% +$1.45M 0.01% 812
2025
Q4
$1.83M Buy
12,514
+11,510
+1,146% +$2.62M ﹤0.01% 1571
2025
Q3
$228K Buy
+1,004
New +$206K ﹤0.01% 2292
2024
Q1
Sell
-1,488
Closed -$271K 2334
2023
Q4
$271K Buy
+1,488
New +$258K ﹤0.01% 1913

Other funds holding MSGS

Corient Private Wealth's MSGS Position: Q1 2026 in Review

Corient Private Wealth increased its Madison Square Garden (MSGS) stake by 39% in Q1 2026, buying an estimated $1.45M and bringing the position to 17,380 shares worth $5.53M. The position accounts for 0.01% of the portfolio, ranked #812.

Corient Private Wealth first reported a position in MSGS in Q4 2023 and has held it in 4 quarters since. 408 funds tracked by Wall St. Rank hold MSGS as of Q1 2026.

  • Corient Private Wealth held 17,380 shares of Madison Square Garden worth $5.53M as of Q1 2026.
  • Corient Private Wealth bought 4,866 Madison Square Garden shares in Q1 2026, an estimated $1.45M.
  • Madison Square Garden made up 0.01% of Corient Private Wealth's portfolio in Q1 2026, its #812 holding.
  • Corient Private Wealth first reported a position in Madison Square Garden in Q4 2023 and has held it in 4 quarters since.
  • 408 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.